Compare · BMGL vs CHE
BMGL vs CHE
Side-by-side comparison of Basel Medical Group Ltd (BMGL) and Chemed Corp (CHE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BMGL and CHE operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- CHE is the larger of the two at $5.61B, about 506.5x BMGL ($11.1M).
- Over the past year, BMGL is down 84.5% and CHE is down 25.7% - CHE leads by 58.7 points.
- CHE has hit the wire 11 times in the past 4 weeks while BMGL has been quiet.
- CHE has more recent analyst coverage (6 ratings vs 0 for BMGL).
- Company
- Basel Medical Group Ltd
- Chemed Corp
- Price
- $0.60-8.22%
- $423.21-0.74%
- Market cap
- $11.1M
- $5.61B
- 1M return
- +7.10%
- -0.58%
- 1Y return
- -84.45%
- -25.71%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2025
- News (4w)
- 0
- 11
- Recent ratings
- 0
- 6
Chemed Corp
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Latest BMGL
- SEC Form 3 filed by new insider Soong Kwek Yoon
- SEC Form 3 filed by new insider Lu Jianing Jn
- SEC Form 3 filed by new insider Chen Tony
- SEC Form 3 filed by new insider Chhoa Darren Yen Feng
- SEC Form 3 filed by new insider Tan Boon Chye
- SEC Form 3 filed by new insider Fung Keng Leong
- SEC Form 6-K filed by Basel Medical Group Ltd
- SEC Form 6-K filed by Basel Medical Group Ltd
- Compliance With Nasdaq Periodic Filing Requirement
- Amendment: SEC Form 20-F/A filed by Basel Medical Group Ltd
Latest CHE
- Director Walsh George J Iii sold $218,915 worth of Capital Stock (500 units at $437.83), decreasing direct ownership by 13% to 3,209 units (SEC Form 4)
- Chemed Corp filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Walsh George J Iii was granted 386 units of Capital Stock, increasing direct ownership by 12% to 3,709 units (SEC Form 4)
- Director Mount John Meredith Jr. was granted 386 units of Capital Stock, increasing direct ownership by 42% to 1,316 units (SEC Form 4)
- Director Mccarthy Eileen P was granted 386 units of Capital Stock, increasing direct ownership by 45% to 1,241 units (SEC Form 4)
- Director Lindell Andrea R was granted 386 units of Capital Stock, increasing direct ownership by 7% to 5,925 units (SEC Form 4)
- Director Heaney Christopher J was granted 386 units of Capital Stock, increasing direct ownership by 16% to 2,775 units (SEC Form 4)
- Director Grace Patrick P was granted 386 units of Capital Stock, increasing direct ownership by 12% to 3,723 units (SEC Form 4)
- Director Delyons Ron was granted 386 units of Capital Stock, increasing direct ownership by 23% to 2,052 units (SEC Form 4)
- Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend